Covering biotech, medical devices, healthcare IT, diagnostics, and drug pipeline developments.
Explore Single Use Bioreactor Market trends, growth drivers & forecasts to 2035. Insights on technology, applications & key players shaping global biotech | NextGen Intelligence Stats
The global Single Cell Protein market size is projected to be worth $11.32 billion in 2024 and reach $30.06 billion by 2035, exhibiting a CAGR of 9.45%.
Projected to grow at a 12.7% CAGR, the single-use bioreactors market will reach $35.4B by 2035. Explore drivers, segmentation, and emerging industry trends shaping the future of biomanufacturing.
Global Animal Vaccine Market continues on a promising upward trajectory, with revenue expected to increase from around US$ 13.36 billion in 2024 to nearly US$ 34.48 billion by 2035, registering a strong CAGR of 8.5% over the forecast period.
The Single Cell Protein Market was valued at USD 11.32 Bn in 2024, with North America holding 35.4% revenue share, and is set to grow strongly by 2035.
Industry forecasts indicate that the global CRISPR market will register consistent expansion, with market value projected to escalate from US$ 7.82 billion in 2024 to approximately US$ 46.10 billion by 2035, growing at a CAGR of 15.1%.
North America led the pulmonary arterial hypertension market in 2024 with a 31.8% share, highlighting its dominance and steady growth outlook to 2035.
The At-Home Testing Market valued at around USD 14.56 Billion in 2024, reaching a valuation of US$ 32.82 billion by 2035, and is expected to expand at a CAGR of 11.5% from 2025 to 2035.
The glucose biosensors market stood at USD 9.56 billion in 2024 and is expected to reach USD 24.08 billion by 3035, growing at a CAGR of 8.3%.
The infusion pump market is valued at about $19.9 billion in 2025 and is expected to grow at a CAGR of 7.4%, driven by tech advances and rising chronic diseases
Industry analysis suggests the global infusion pump market will nearly double in value, moving from US$ 12.45 billion in 2024 to US$ 27.30 billion by 2035, supported by a 7.1% CAGR throughout 2025–2035.
The global cell and gene therapy manufacturing market will surpass $834.1B by 2035, driven by demand, bioprocessing advances, and regulatory growth.
Cell and Gene Therapy Manufacturing Market is led by Cell Therapy Manufacturing holding a 60.19% share in 2023, including stem and non-stem cell therapies.
The Preclinical CRO Market around the globe was worth USD 10.02 billion in 2024 and is anticipated to reach USD 7.08 billion during the forecast period of 3035, growing at a CAGR of 9.2%.
Explore in-depth research on the preclinical CRO market, including size, segmentation, regional analysis, growth drivers, and outsourcing trends.
The cell and gene therapy manufacturing market was valued at USD 134.48B in 2024, projected to reach USD 834.1B by 2035, growing at a CAGR of 15.5%.
